Upgrade to SI Premium - Free Trial

Amarin (AMRN) Files Suit Against FDA Related to Off-Label Promotion

May 7, 2015 4:18 PM
Amarin Corp plc (NASDAQ: AMRN) and four independent physicians, in support of improved patient care, filed a lawsuit to permit ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News Litigation Trader Talk Trading Halts

Next Articles